With the use of fertility and pregnancy rapid test kits, women can swiftly and simply establish whether they are ovulating or pregnant. These tests, which are available over-the-counter at pharmacies, use blood or urine samples to find specific hormones in a woman's body. The global market for fertility and pregnancy rapid test kits is driven by factors such as the increasing incidence of gynecological issues, infertility, and the availability of quick and convenient tests. These kits can detect hormones such as hCG, LH, FSH, and sperm count in males. The market is growing due to rising demand for decentralized diagnostic technologies, alluring product features, and smartphone app connectivity. As a result, the market is expected to expand significantly in the coming years.
Market Dynamics
Rapid test kits for fertility and pregnancy are an easy, convenient way for people to test their fertility. These kits are used to check for the presence of reproductive hormones such follicle-stimulating hormone (FSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). Self-contained pregnancy and fertility rapid test kits are becoming more and more well-liked because of their speedy results and ease of use. Pregnancy tests that are quick and accurate let women make an early decision on whether to immediately confirm or rule out their pregnancy. For instance, Prega News Advanced, a brand-new and sophisticated pregnancy detection test kit, was introduced by Mankind Pharma in April 2022 in the Indian market. It is the simplest and most practical way to test for pregnancy at home because the product contains a single-step pregnancy test equipment that does not involve collecting pee in a dropper or a container.
Key features of the study:
- This report provides in-depth analysis of the global fertility and pregnancy rapid test kits market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022, as the base
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players.
- It profiles leading players in the global fertility and pregnancy rapid test kits market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include SPD Swiss Precision Diagnostic GmbH, DCC Plc., Procter & Gamble, Abbott Laboratories, Quidel Corporation, bioMerieux SA, Church & Dwight Co., Inc., Prestige Brands Holdings, Inc., and Geratherm Medical AG.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global fertility and pregnancy rapid test kits market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Fertility And Pregnancy Rapid Test Kits market
Detailed Segmentation:
- Global Fertility and Pregnancy Rapid Test Kits Market, By Product Type:
- Pregnancy Rapid Tests
- Line-Indicator Devices
- Strips/Dip Sticks
- Mid-Stream
- Cassettes
- Digital
- Fertility Rapid Tests
- Line-Indicator
- Digital
- Global Fertility and Pregnancy Rapid Test Kits Market, By Test Type:
- LH Urine
- FSH Urine
- hCG Blood
- hCG Urine
- Global Fertility and Pregnancy Rapid Test Kits Market, By Distribution Channel:
- Hospital Channel
- Retail Channel
- Online Channel
- Global Fertility and Pregnancy Rapid Test Kits Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- u.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Swiss Precision Diagnostic GmbH*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DCC Plc.
- Procter & Gamble
- Abbott Laboratories
- Quidel Corporation
- bioMerieux SA
- Church & Dwight Co., Inc.
- Prestige Brands Holdings, Inc.
- Geratherm Medical AG
"*" marked represents similar segmentation in other categories in the respective section.